Across the United States and worldwide, MSM continue to be a group disproportionately affected by STDs and HIV, but we still need better data and better tools to guide prevention efforts.
On the horizon is a greater integration of services and population level outcomes with health rather than individual disease case numbers as the sole measure of success or failure. And syphilis reminds us of why this is so utterly necessary.
Long-awaited results were released today in the New England Journal of Medicine of a study on the effectiveness of a single daily tablet for preventing HIV transmission among those at high risk of infection.
Recent data indicate that HIV and AIDS affect gay and bisexual men at rates grossly disproportional to other groups. Why did it take CDC so long to ask these questions and what will we do to answer them?